Covered recipient · General Payments record
FARDAD ESMAILIAN
Allopathic & Osteopathic Physicians Thoracic Surgery (Cardiothoracic Vascular Surgery)
General Payments · PY2018–2024
$23,190.78
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $4,175.20 | 3 |
| Consulting Fee | $2,200.00 | 2 |
| Food and Beverage | $619.51 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TRANSMEDICS, INC. | $4,175.20 | 3 |
| Abbott Laboratories | $2,200.00 | 2 |
| ABIOMED | $169.78 | 2 |
| Edwards Lifesciences Corporation | $167.97 | 3 |
| XVIVO Perfusion Inc. | $146.24 | 1 |
| ATRICURE, INC. | $119.59 | 3 |
| LeMaitre Vascular, Inc. | $15.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $1,650.00 | 03/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125438309 | CMS |
| Abbott Laboratories | $550.00 | 03/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125438311 | CMS |
| ABIOMED | $42.23 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142217636 | CMS |
| ABIOMED | $127.55 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142217648 | CMS |
| ATRICURE, INC. | $50.87 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132864362 | CMS |
| ATRICURE, INC. | $25.44 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132898780 | CMS |
| ATRICURE, INC. | $43.28 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132836253 | CMS |
| Edwards Lifesciences Corporation | $51.44 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138767350 | CMS |
| Edwards Lifesciences Corporation | $64.45 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138767364 | CMS |
| Edwards Lifesciences Corporation | $52.08 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138767398 | CMS |
| LeMaitre Vascular, Inc. | $15.93 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138053241 | CMS |
| TransMedics, Inc. | $1,273.48 | 11/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154757052 | CMS |
| TransMedics, Inc. | $1,755.18 | 11/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154757054 | CMS |
| TransMedics, Inc. | $1,146.54 | 11/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154757056 | CMS |
| XVIVO Perfusion Inc. | $146.24 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087844301 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.